$MNLO Two questions answered and let’s decide OK? What exactly was ARNA price “before” they announced the RS. I know the answer but will let you post it. How long did they stay in that range. 1- Are we stuck with ARNA? Any more examples in biotech? 2- POST ONE MORE EXAMPLE of a biotech that did not fear delisting (flirting at the $1 level) but yet RDd. I mean they were in the $2+ level. The policy of dilution followed by RS would be a norm if this is true haha